Scientific Advisory Committee

Milana Dolezal, MD, MSc

Milana Dolezal, MD, MSc is a Principal Investigator for National Cancer Institute and industry-sponsored cancer treatment clinical trials at California Pacific Medical Center. She leads research on tumor biology and targeted cancer therapies, especially in women’s malignancies.

W. Lawrence Drew, MD, PhD

W. Lawrence Drew, MD, PhD is the Director, Clinical Virology Laboratory and Professor of Laboratory Medicine at the School of Medicine, University of California, San Francisco. He has overseen multiple studies of cytomegalovirus infection in people with HIV, including a nationwide, 13-center collaborative study.

William D. Figg, PharmD

William D. Figg, PharmD is Senior Investigator/Head of the Clinical Pharmacology Program in the Office of the Clinical Director, Center for Cancer Research, National Cancer Institute at the National Institutes of Health. He is also the Head of the Molecular Pharmacology Section, Deputy Chief of the Genitourinary Malignancies Branch, Co-Director of the Office of the Translational Resources and Associate Director of the Center for Cancer Research, NCI, NIH.

W. David Hardy, MD

Dr. W. David Hardy is a scientific and medical consultant focusing on developing novel vaccine and cure/remission strategies for human viral diseases. He serves as Adjunct Clinical Professor of Medicine at the Keck School of Medicine of USC. He served as Senior Director of Research at Whitman-Walker Health in Washington D.C., overseeing NIH-funded ACTG trials and HIV Cohort studies and industry-sponsored trials from 2015-2018. During that time he also held an academic appointment as Adjunct Professor of Medicine at Johns Hopkins University School of Medicine. Hardy received his M.D. from Baylor College of Medicine and completed his residency at Harbor-UCLA Medical Center. Dr Hardy currently serves as Chair of the Education Committee and member of the Executive Committee of the American Academy of HIV Medicine.

Theodore Ruel, MD

Theodore Ruel, MD is a Professor of Pediatrics in the School of Medicine, University of California, San Francisco. His research focuses on the optimization of treatment outcomes of children born with HIV. He serves as vice-chair of the National Institutes of Health/Department of Health and Human Services Panel on Antiretroviral Therapy and Medical Management of HIV-infected Children and as advisor to the Pediatric AIDS Working Group at the World Health Organization.